Results 251 to 260 of about 283,224 (387)
Enhancing the therapeutic potential of FDA-approved ifosfamide and 5-fluorouracil through rational chemical modifications for endometrial cancer treatment. [PDF]
Tanveer L, Batool S, Mubeen H, Shahid I.
europepmc +1 more source
Phase 2 study of combination SPI-1620 with docetaxel as second-line advanced biliary tract cancer treatment [PDF]
A Rai+30 more
core +3 more sources
What's New? Mismatch repair deficiency (dMMR) in rectal cancer is rare, and knowledge about tumor biological behavior, response to treatment, and clinical outcomes in this subset of patients is limited. This nationwide cohort study including 182 patients with dMMR rectal cancer found that they were younger and had more poorly differentiated tumors ...
Renee A. Lunenberg+14 more
wiley +1 more source
Prediction of suitable drug for keloid through analytic hierarchy process and topological indices. [PDF]
Janagi K+3 more
europepmc +1 more source
Points from Letters: Intravenous Fluorouracil and Tachycardia [PDF]
M. E. Carpenter
openalex +1 more source
What's New? Prognostic assessment in metastatic colorectal cancer (mCRC), which is currently based on scores derived from clinical trials, requires refinement to enhance treatment outcomes and quality of care. In this study, the authors evaluated real‐world data from the German tumor registry to prospectively validate a modified mCRC prognostic score ...
Karin Potthoff+19 more
wiley +1 more source
Advanced-stage colorectal cancer in the context of coronavirus disease-19, highlighting socioeconomic disparities and outcomes: a case report. [PDF]
Brim H+7 more
europepmc +1 more source
Thionucleotide formation in Escherichia coli transfer ribonucleic acid in the presence of 5‐fluorouracil [PDF]
Alan R. Hipkiss+2 more
openalex +1 more source